uniquelytoronto.com
The FDA approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.
Click on this link to read the Official US Food & Drug Administration Press Release : FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe form…